BRIEF-Syndax Pharma to offer common stock in public offering

* Syndax pharmaceuticals inc- it plans to offer and sell $50 million of its common stock in an underwritten public offering Source text for Eikon: Further company coverage:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.